Hudson Bay Capital Management
AURA icon

Hudson Bay Capital Management’s Aura Biosciences AURA Stock Holding History

Hudson Bay Capital Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-53,072
Closed -$470K – 729
2023
Q4 		$470K Buy
+53,072
New +$449K ﹤0.01% 560

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Hudson Bay Capital Management's AURA Position: Q1 2024 in Review

Hudson Bay Capital Management sold out of Aura Biosciences (AURA) in Q1 2024, closing a stake of 53,072 shares — an estimated $470K sold.

Hudson Bay Capital Management first reported a position in AURA in Q4 2023 and held it in 1 quarter. The position peaked at $470K in Q4 2023. 78 funds tracked by Wall St. Rank hold AURA as of Q1 2024.

  • Hudson Bay Capital Management reported no remaining Aura Biosciences position as of Q1 2024 after selling out during the quarter.
  • Hudson Bay Capital Management sold 53,072 Aura Biosciences shares in Q1 2024, an estimated $470K.
  • Hudson Bay Capital Management first reported a position in Aura Biosciences in Q4 2023 and held it in 1 quarter.
  • Hudson Bay Capital Management's Aura Biosciences position peaked at $470K in Q4 2023.
  • 78 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2024.

Based on Hudson Bay Capital Management's 13F filing for Q1 2024, filed 15 May 2024.